UiPath (NYSE:PATH) Stock Price Up 1.7%

UiPath Inc. (NYSE:PATHGet Free Report)’s share price traded up 1.7% during trading on Friday . The company traded as high as $12.23 and last traded at $12.22. 1,373,520 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 10,023,358 shares. The stock had previously closed at $12.02.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Needham & Company LLC reissued a “hold” rating on shares of UiPath in a research report on Friday, September 6th. BMO Capital Markets increased their price objective on shares of UiPath from $14.00 to $15.00 and gave the stock a “market perform” rating in a research report on Friday, September 6th. Barclays boosted their target price on shares of UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a report on Friday, September 6th. DA Davidson increased their price target on UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Finally, Truist Financial reissued a “hold” rating and issued a $14.00 price objective (down from $32.00) on shares of UiPath in a research note on Thursday, May 30th. Sixteen analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $17.71.

Read Our Latest Stock Analysis on UiPath

UiPath Trading Up 4.1 %

The firm’s 50-day moving average is $12.12 and its 200-day moving average is $16.27. The firm has a market cap of $7.17 billion, a price-to-earnings ratio of -78.19 and a beta of 0.87.

UiPath (NYSE:PATHGet Free Report) last posted its earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The company had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. During the same period in the previous year, the firm posted ($0.09) earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Analysts forecast that UiPath Inc. will post -0.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Intech Investment Management LLC lifted its stake in UiPath by 3.1% during the 4th quarter. Intech Investment Management LLC now owns 14,324 shares of the healthcare company’s stock valued at $356,000 after acquiring an additional 426 shares in the last quarter. Global Financial Private Client LLC grew its position in UiPath by 9.3% in the 1st quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock worth $144,000 after purchasing an additional 551 shares in the last quarter. Principal Financial Group Inc. grew its position in UiPath by 1.7% in the 1st quarter. Principal Financial Group Inc. now owns 36,772 shares of the healthcare company’s stock worth $834,000 after purchasing an additional 622 shares in the last quarter. GAMMA Investing LLC increased its stake in UiPath by 40.2% in the 1st quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock valued at $50,000 after buying an additional 632 shares during the last quarter. Finally, Lindbrook Capital LLC lifted its position in shares of UiPath by 46.0% during the 1st quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock worth $46,000 after buying an additional 639 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company’s stock.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.